Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Makinen P < Makinen T < Makinen V

T Makinen
NONE (BIBLIO)
000302
000353
000424
000737
000793
000832
000A03
000A04
000A14
000A30
000B74
000D96
000E74
000F54
000F86
001018
001221
001502
001636
001870
001948
001B05
001B68
001D27
002041
002384
002393
002977
002A14
002A33
002A82
002E83
002F96
003002
003474
003493
003554
003829
003992
003D62
003D88
003E26
003F60
004096
004314
004348
004349
004479
004609
004A95
004B04
004B53
004B67
004C92
005076
005138
005145
005637
005750
005958
005974
005A57
006279
006280
006307
006353
006487
007B82
013B56
014009
T. Makinen
NONE (BIBLIO)
000478
000591
000786
000A52
000E32
000E80
001186
001307
001421
001733
001C42
001E33
001F91
002020
002200
002260
003068
003302
003681
003E32
003E51
003E84
004D04
004D97
004E72
005636
005649
005786
005899
005900
005901
006363
Taija Makinen
Lymphatic Development Laboratory, Cancer Research UK London Research InstituteLondon WC2A 3PXGBR11 aut.22 aut.
Royaume-Uni
London WC2A 3PX
004960
Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom
Royaume-Uni
Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3PX
London WC2A 3PX
006307
Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln’s Inn Fields, London WC2A 3LY, UK
Royaume-Uni
Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln’s Inn Fields, London WC2A 3LY
London WC2A 3LY
003302
Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK. Electronic address: taija.makinen@cancer.org.uk.
Royaume-Uni
Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY
London WC2A 3LY
003224
Royaume-Uni
Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London
LondresAngleterreGrand Londres
007727
Lymphatic Development Laboratory, Cancer Research UK London Research InstituteLondonGBR15 aut.16 aut.
Royaume-Uni
LondresAngleterreGrand Londres
005479
Lymphatic Development Laboratory, Cancer Research UK London Research Institute, London, United Kingdom.
Royaume-Uni
Lymphatic Development Laboratory, Cancer Research UK London Research Institute, London
LondresAngleterreGrand Londres
004F01
Finlande
Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, PO Box 21 (Haartmaninkatu 3), 00014, Helsinki
Université d'Helsinki
HelsinkiUusimaa
00A174
Finlande
Molecular/Cancer Biology Laboratory, Haartman Institute, University of Helsinki, Helsinki
Université d'Helsinki
HelsinkiUusimaa
00B299
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Suède
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala
Université d'Uppsala
UppsalaSvealandEast Middle Sweden
014009
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Suède
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala
Université d'Uppsala
UppsalaSvealandEast Middle Sweden
002898
Molecular/Cancer Biology Laboratory, Biomedicum Helsinki, University of Helsinki, Helsinki FI-00290, Finland;
Finlande
Molecular/Cancer Biology Laboratory, Biomedicum Helsinki, University of Helsinki, Helsinki FI-00290
Université d'Helsinki
HelsinkiUusimaa
004A34
Department of Pathology, Haartman Institute, University of Helsinki, Helsinki FI-00290, Finland;
Finlande
Department of Pathology, Haartman Institute, University of Helsinki, Helsinki FI-00290
Université d'Helsinki
HelsinkiUusimaa
004A34
From the Wihuri Research Institute (A.A., M.R.R., S.K., K.A.) and Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland (A.A., M.R.R., K.A.); and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden (T.M.).
Université d'Helsinki
Finlande
HelsinkiUusimaa
000E68
007727
Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln’s Inn Fields, London, WC2A 3LY UK
WC2A 3LY UK
004314

006C67
Lymphatic Development Laboratory, Cancer Research UK London Research Institute, London WC2A 3PX, U
U
004108
NONE
003E84
004D31
U
004108
WC2A 3LY UK
004314

<g>
<k>Makinen T</k>
<l>
<g>
<k>T Makinen</k>
<l>
<g>
<k>
<affiliation>NONE (BIBLIO)</affiliation>
</k>
<l>
<i>000302</i>
<i>000353</i>
<i>000424</i>
<i>000737</i>
<i>000793</i>
<i>000832</i>
<i>000A03</i>
<i>000A04</i>
<i>000A14</i>
<i>000A30</i>
<i>000B74</i>
<i>000D96</i>
<i>000E74</i>
<i>000F54</i>
<i>000F86</i>
<i>001018</i>
<i>001221</i>
<i>001502</i>
<i>001636</i>
<i>001870</i>
<i>001948</i>
<i>001B05</i>
<i>001B68</i>
<i>001D27</i>
<i>002041</i>
<i>002384</i>
<i>002393</i>
<i>002977</i>
<i>002A14</i>
<i>002A33</i>
<i>002A82</i>
<i>002E83</i>
<i>002F96</i>
<i>003002</i>
<i>003474</i>
<i>003493</i>
<i>003554</i>
<i>003829</i>
<i>003992</i>
<i>003D62</i>
<i>003D88</i>
<i>003E26</i>
<i>003F60</i>
<i>004096</i>
<i>004314</i>
<i>004348</i>
<i>004349</i>
<i>004479</i>
<i>004609</i>
<i>004A95</i>
<i>004B04</i>
<i>004B53</i>
<i>004B67</i>
<i>004C92</i>
<i>005076</i>
<i>005138</i>
<i>005145</i>
<i>005637</i>
<i>005750</i>
<i>005958</i>
<i>005974</i>
<i>005A57</i>
<i>006279</i>
<i>006280</i>
<i>006307</i>
<i>006353</i>
<i>006487</i>
<i>007B82</i>
<i>013B56</i>
<i>014009</i>
</l>
<n>70</n>
<t>70</t>
</g>
</l>
<n>1</n>
<t>70</t>
</g>
<g>
<k>T. Makinen</k>
<l>
<g>
<k>
<affiliation>NONE (BIBLIO)</affiliation>
</k>
<l>
<i>000478</i>
<i>000591</i>
<i>000786</i>
<i>000A52</i>
<i>000E32</i>
<i>000E80</i>
<i>001186</i>
<i>001307</i>
<i>001421</i>
<i>001733</i>
<i>001C42</i>
<i>001E33</i>
<i>001F91</i>
<i>002020</i>
<i>002200</i>
<i>002260</i>
<i>003068</i>
<i>003302</i>
<i>003681</i>
<i>003E32</i>
<i>003E51</i>
<i>003E84</i>
<i>004D04</i>
<i>004D97</i>
<i>004E72</i>
<i>005636</i>
<i>005649</i>
<i>005786</i>
<i>005899</i>
<i>005900</i>
<i>005901</i>
<i>006363</i>
</l>
<n>32</n>
<t>32</t>
</g>
</l>
<n>1</n>
<t>32</t>
</g>
<g>
<k>Taija Makinen</k>
<l>
<g>
<k>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>Lymphatic Development Laboratory, Cancer Research UK London Research Institute</s1>
<s2>London WC2A 3PX</s2>
<s3>GBR</s3>
<sZ>11 aut.</sZ>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>London WC2A 3PX</wicri:noRegion>
</affiliation>
</k>
<l>
<i>004960</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="1">
<nlm:aff id="A1"> Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea> Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3PX</wicri:regionArea>
<wicri:noRegion>London WC2A 3PX</wicri:noRegion>
</affiliation>
</k>
<l>
<i>006307</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="1">
<nlm:aff id="aff1">Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln’s Inn Fields, London WC2A 3LY, UK</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln’s Inn Fields, London WC2A 3LY</wicri:regionArea>
<wicri:noRegion>London WC2A 3LY</wicri:noRegion>
</affiliation>
</k>
<l>
<i>003302</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="1">
<nlm:affiliation>Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK. Electronic address: taija.makinen@cancer.org.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY</wicri:regionArea>
<wicri:noRegion>London WC2A 3LY</wicri:noRegion>
</affiliation>
</k>
<l>
<i>003224</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="3">
<country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country>
<wicri:regionArea>Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</k>
<l>
<i>007727</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="3">
<inist:fA14 i1="11">
<s1>Lymphatic Development Laboratory, Cancer Research UK London Research Institute</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</k>
<l>
<i>005479</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="3">
<nlm:aff id="JCI58050">Lymphatic Development Laboratory, Cancer Research UK London Research Institute, London, United Kingdom.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country>
<wicri:regionArea>Lymphatic Development Laboratory, Cancer Research UK London Research Institute, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</k>
<l>
<i>004F01</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="4">
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, PO Box 21 (Haartmaninkatu 3), 00014, Helsinki</wicri:regionArea>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
</affiliation>
</k>
<l>
<i>00A174</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="4">
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Molecular/Cancer Biology Laboratory, Haartman Institute, University of Helsinki, Helsinki</wicri:regionArea>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
</affiliation>
</k>
<l>
<i>00B299</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="4">
<nlm:aff id="A2">Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Suède</country>
<wicri:regionArea>Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala</wicri:regionArea>
<orgName type="university">Université d'Uppsala</orgName>
<placeName>
<settlement type="city">Uppsala</settlement>
<region nuts="1">Svealand</region>
<region nuts="1">East Middle Sweden</region>
</placeName>
</affiliation>
</k>
<l>
<i>014009</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="4">
<nlm:aff id="JCI75392">Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Suède</country>
<wicri:regionArea>Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala</wicri:regionArea>
<orgName type="university">Université d'Uppsala</orgName>
<placeName>
<settlement type="city">Uppsala</settlement>
<region nuts="1">Svealand</region>
<region nuts="1">East Middle Sweden</region>
</placeName>
</affiliation>
</k>
<l>
<i>002898</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="4">
<nlm:aff id="aff4">Molecular/Cancer Biology Laboratory, Biomedicum Helsinki, University of Helsinki, Helsinki FI-00290, Finland;</nlm:aff>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Molecular/Cancer Biology Laboratory, Biomedicum Helsinki, University of Helsinki, Helsinki FI-00290</wicri:regionArea>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
</affiliation>
</k>
<l>
<i>004A34</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="4">
<nlm:aff id="aff5">Department of Pathology, Haartman Institute, University of Helsinki, Helsinki FI-00290, Finland;</nlm:aff>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Department of Pathology, Haartman Institute, University of Helsinki, Helsinki FI-00290</wicri:regionArea>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
</affiliation>
</k>
<l>
<i>004A34</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation wicri:level="4">
<nlm:affiliation>From the Wihuri Research Institute (A.A., M.R.R., S.K., K.A.) and Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland (A.A., M.R.R., K.A.); and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden (T.M.).</nlm:affiliation>
<orgName type="university">Université d'Helsinki</orgName>
<country>Finlande</country>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
</affiliation>
</k>
<l>
<i>000E68</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation></affiliation>
</k>
<l>
<i>007727</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation>
<nlm:aff id="Aff1">Lymphatic Development Laboratory, Cancer Research UK London Research Institute, 44 Lincoln’s Inn Fields, London, WC2A 3LY UK</nlm:aff>
<wicri:noCountry code="subfield">WC2A 3LY UK</wicri:noCountry>
</affiliation>
</k>
<l>
<i>004314</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation>
<nlm:aff id="aff1"></nlm:aff>
</affiliation>
</k>
<l>
<i>006C67</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation>
<nlm:aff id="aff9">Lymphatic Development Laboratory, Cancer Research UK London Research Institute, London WC2A 3PX, U</nlm:aff>
<wicri:noCountry code="subfield">U</wicri:noCountry>
</affiliation>
</k>
<l>
<i>004108</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<affiliation>NONE</affiliation>
</k>
<l>
<i>003E84</i>
<i>004D31</i>
</l>
<n>2</n>
<t>2</t>
</g>
<g>
<k>
<wicri:noCountry code="subfield">U</wicri:noCountry>
</k>
<l>
<i>004108</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<wicri:noCountry code="subfield">WC2A 3LY UK</wicri:noCountry>
</k>
<l>
<i>004314</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>21</n>
<t>22</t>
</g>
</l>
<n>3</n>
<t>124</t>
</g>

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024